| HGNC Family | Non-coding RNAs |
| Name | microRNA 149 |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nmiR-149—including its mature form, its passenger strand (miR-149*), and its isoforms miR‑149‑5p/3p—has emerged as a critical regulator in multiple human diseases. Several genetic association studies have demonstrated that single‐nucleotide polymorphisms in the miR‑149 precursor contribute to altered cancer risk and clinical outcomes in gastrointestinal and cardiovascular conditions, among others."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "7"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn oncologic contexts, miR‑149 chiefly acts as a tumor suppressor by inhibiting cell proliferation, migration, and invasion. Functional studies have revealed that miR‑149 directly targets key oncogenic mediators—including GIT1 in breast cancer"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": ", SP1 in colorectal cancer"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": ", and ZBTB2 in gastric cancer"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": "—while its action in hepatocellular carcinoma involves the suppression of PPM1F."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": " Similarly, miR‑149 impedes glioblastoma progression by modulating AKT1‑dependent signaling"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": ", and its downregulation has been linked to enhanced tumor growth in astrocytomas"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "13"}]}, {"type": "t", "text": "and osteosarcomas."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nThe expression of miR‑149 is itself subject to regulation. Under cellular stress, p53 directly upregulates miR‑149* in melanoma cells, triggering a cascade that targets glycogen synthase kinase‑3α and ultimately promotes resistance to apoptosis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "15"}]}, {"type": "t", "text": " In parallel, direct targeting of Akt1 and E2F1 by miR‑149* has been shown to induce apoptosis in neuroblastoma and HeLa cells"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "16"}]}, {"type": "t", "text": ", whereas diminished miR‑149 levels via epigenetic silencing contribute to chemoresistance in breast cancer through NDST1 regulation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "17"}]}, {"type": "t", "text": " Notably, in T-cell acute lymphoblastic leukemia, miR‑149* expression is elevated and exerts oncogenic effects by downregulating the tumor suppressor JunB, reflecting a context‑dependent dichotomy."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "18"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nApart from its roles in growth regulation, miR‑149 influences treatment responses. In glioblastoma, restoration of miR‑149 enhances chemosensitivity to temozolomide"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "19"}]}, {"type": "t", "text": ", and in invasive breast cancer models, increased miR‑149 levels reduce cell migration and lung colonization, partly by impairing focal adhesion dynamics."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "20"}]}, {"type": "t", "text": " In colorectal cancer cells, overexpression of miR‑149* has been found to downregulate CDK4/6, contributing to cell‑cycle arrest and reduced proliferation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "22"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nNon‑coding RNA “sponging” represents an additional layer of miR‑149 regulation. In nasopharyngeal carcinoma, the long non‑coding RNA LINC00460 promotes tumor progression by sequestering miR‑149‑5p, thereby modulating IL6 signaling."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "23"}]}, {"type": "t", "text": " In non‑small cell lung cancer, HNF1A‑AS1 similarly binds miR‑149‑5p to derepress CDK6."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "24"}]}, {"type": "t", "text": " Likewise, circular RNAs such as circ_0124644 in atherosclerosis and circCTNNA1 in colon cancer act as competing endogenous RNAs that sequester miR‑149‑5p, leading to aberrant expression of targets like PAPP‑A"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "25"}]}, {"type": "t", "text": "and FOXM1."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "26"}]}, {"type": "t", "text": " Furthermore, increased levels of circulating miR‑149‑3p have been proposed as a diagnostic biomarker in melanoma."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "27"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond cancer, miR‑149‑5p plays important roles in non‑malignant diseases. In osteoarthritis, reduced miR‑149 expression correlates with increased levels of pro‑inflammatory cytokines and impaired chondrocyte survival and autophagy."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "28"}]}, {"type": "t", "text": " In type 1 diabetes, miR‑149‑5p modulates β‑cell apoptosis by regulating pro‑apoptotic Bcl‑2 family members"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "30"}]}, {"type": "t", "text": ", and polymorphisms in the miR‑149 precursor have been linked to altered myocardial infarction outcomes due to diminished production of mature miR‑149 and consequent dysregulation of apoptotic pathways."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "31"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nCollectively, these findings illustrate the multifaceted functions of miR‑149 and its related isoforms as context‑dependent modulators of cell survival, proliferation, migration, and apoptosis. By directly targeting a range of oncogenes and key components of cell‑cycle and signaling pathways—and being itself regulated by genetic, epigenetic, and non‑coding RNA interactions—miR‑149 shows promise as both a prognostic biomarker and a potential therapeutic target across a spectrum of diseases.\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Zhensheng Liu, Guojun Li, Sheng Wei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cncr.25323"}], "href": "https://doi.org/10.1002/cncr.25323"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20549817"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20549817"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Young Joo Jeon, Ok Joon Kim, Su Yeoun Kim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of the miR-146a, miR-149, miR-196a2, and miR-499 polymorphisms with ischemic stroke and silent brain infarction risk."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arterioscler Thromb Vasc Biol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/ATVBAHA.112.300251"}], "href": "https://doi.org/10.1161/ATVBAHA.112.300251"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23202363"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23202363"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Dae Ho Ahn, HyungChul Rah, Young-Kook Choi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of the miR-146aC>G, miR-149T>C, miR-196a2T>C, and miR-499A>G polymorphisms with gastric cancer risk and survival in the Korean population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Carcinog (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/mc.21962"}], "href": "https://doi.org/10.1002/mc.21962"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23001871"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23001871"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "M W Zhang, M J Jin, Y X Yu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Associations of lifestyle-related factors, hsa-miR-149 and hsa-miR-605 gene polymorphisms with gastrointestinal cancer risk."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Carcinog (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/mc.20863"}], "href": "https://doi.org/10.1002/mc.20863"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21976437"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21976437"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Qian Xu, Jing-wei Liu, Yuan Yuan "}, {"type": "b", "children": [{"type": "t", "text": "Comprehensive assessment of the association between miRNA polymorphisms and gastric cancer risk."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mutat Res Rev Mutat Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.mrrev.2014.09.004"}], "href": "https://doi.org/10.1016/j.mrrev.2014.09.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25795117"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25795117"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Panagiotis Dikeakos, George Theodoropoulos, Spyros Rizos, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of the miR-146aC>G, miR-149T>C, and miR-196a2T>C polymorphisms with gastric cancer risk and survival in the Greek population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol Rep (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11033-013-2953-0"}], "href": "https://doi.org/10.1007/s11033-013-2953-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24379078"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24379078"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Jung-Hoon Sung, Sang-Hoon Kim, Woo-In Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miRNA polymorphisms (miR‑146a, miR‑149, miR‑196a2 and miR‑499) are associated with the risk of coronary artery disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2016.5495"}], "href": "https://doi.org/10.3892/mmr.2016.5495"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27430349"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27430349"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "S-H Chan, W-C Huang, J-W Chang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2014.10"}], "href": "https://doi.org/10.1038/onc.2014.10"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24608434"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24608434"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Feng Wang, Yan-Lei Ma, Peng Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Pathol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/path.4078"}], "href": "https://doi.org/10.1002/path.4078"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22821729"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22821729"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Ying Wang, Xiushan Zheng, Zhiyong Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-149 inhibits proliferation and cell cycle progression through the targeting of ZBTB2 in human gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0041693"}], "href": "https://doi.org/10.1371/journal.pone.0041693"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23144691"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23144691"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Gang Luo, Ya-Ling Chao, Bo Tang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.5676"}], "href": "https://doi.org/10.18632/oncotarget.5676"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26498692"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26498692"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "S-J Pan, S-K Zhan, B-G Pei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-149 inhibits proliferation and invasion of glioma cells via blockade of AKT1 signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Immunopathol Pharmacol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/039463201202500405"}], "href": "https://doi.org/10.1177/039463201202500405"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23298478"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23298478"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Dan Li, Pan Chen, Xia-Yu Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Grade-specific expression profiles of miRNAs/mRNAs and docking study in human grade I-III astrocytomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "OMICS (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/omi.2011.0064"}], "href": "https://doi.org/10.1089/omi.2011.0064"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21978395"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21978395"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Rui-Da Xu, Fan Feng, Xiao-Sheng Yu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-149-5p inhibits cell growth by regulating TWEAK/Fn14/PI3K/AKT pathway and predicts favorable survival in human osteosarcoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Immunopathol Pharmacol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/2058738418786656"}], "href": "https://doi.org/10.1177/2058738418786656"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30014744"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30014744"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Lei Jin, Wang Lai Hu, Chen Chen Jiang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1019312108"}], "href": "https://doi.org/10.1073/pnas.1019312108"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21896753"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21896753"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Ruey-Jen Lin, You-Chin Lin, Alice L Yu "}, {"type": "b", "children": [{"type": "t", "text": "miR-149* induces apoptosis by inhibiting Akt1 and E2F1 in human cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Carcinog (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/mc.20647"}], "href": "https://doi.org/10.1002/mc.20647"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20623644"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20623644"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Dong-Xu He, Xiao-Ting Gu, You-Ran Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Methylation-regulated miR-149 modulates chemoresistance by targeting GlcNAc N-deacetylase/N-sulfotransferase-1 in human breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS J (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/febs.13012"}], "href": "https://doi.org/10.1111/febs.13012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25156775"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25156775"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Sheng-Jin Fan, Hui-Bo Li, Gang Cui, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miRNA-149* promotes cell proliferation and suppresses apoptosis by mediating JunB in T-cell acute lymphoblastic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Leuk Res (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.leukres.2015.11.016"}], "href": "https://doi.org/10.1016/j.leukres.2015.11.016"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26725775"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26725775"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Xiaoling She, Zhibin Yu, Yulong Cui, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-128 and miR-149 enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal remodeling in glioblastoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2014.3318"}], "href": "https://doi.org/10.3892/or.2014.3318"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25017996"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25017996"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Annabell Bischoff, Bettina Huck, Bettina Keller, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR149 functions as a tumor suppressor by controlling breast epithelial cell migration and invasion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-13-3319"}], "href": "https://doi.org/10.1158/0008-5472.CAN-13-3319"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25035394"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25035394"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Ismael Sánchez-González, Anja Bobien, Christian Molnar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-149 Suppresses Breast Cancer Metastasis by Blocking Paracrine Interactions with Macrophages."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-19-1934"}], "href": "https://doi.org/10.1158/0008-5472.CAN-19-1934"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31911555"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31911555"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Amriti R Lulla, Michael J Slifker, Yan Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-6883 Family miRNAs Target CDK4/6 to Induce G"}, {"type": "a", "children": [{"type": "t", "text": "sub"}], "href": "sub"}, {"type": "t", "text": "1"}, {"type": "a", "children": [{"type": "t", "text": "/sub"}], "href": "/sub"}, {"type": "t", "text": " Phase Cell-Cycle Arrest in Colon Cancer Cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-17-1767"}], "href": "https://doi.org/10.1158/0008-5472.CAN-17-1767"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29061672"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29061672"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Yong-Gang Kong, Min Cui, Shi-Ming Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA-LINC00460 facilitates nasopharyngeal carcinoma tumorigenesis through sponging miR-149-5p to up-regulate IL6."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2017.10.006"}], "href": "https://doi.org/10.1016/j.gene.2017.10.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28987345"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28987345"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Lu Liu, Yanzhi Chen, Qiaoqing Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "lncRNA HNF1A-AS1 modulates non-small cell lung cancer progression by targeting miR-149-5p/Cdk6."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.29186"}], "href": "https://doi.org/10.1002/jcb.29186"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31243821"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31243821"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Gang Wang, Yu Li, Zhenbin Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circular RNA circ_0124644 exacerbates the ox-LDL-induced endothelial injury in human vascular endothelial cells through regulating PAPP-A by acting as a sponge of miR-149-5p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biochem (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11010-020-03764-0"}], "href": "https://doi.org/10.1007/s11010-020-03764-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32500475"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32500475"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Pengju Chen, Yunfeng Yao, Nan Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circular RNA circCTNNA1 promotes colorectal cancer progression by sponging miR-149-5p and regulating FOXM1 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-020-02757-7"}], "href": "https://doi.org/10.1038/s41419-020-02757-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32699205"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32699205"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Stefano Fogli, Beatrice Polini, Sara Carpi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of plasma microRNAs as new potential biomarkers with high diagnostic power in human cutaneous melanoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/1010428317701646"}], "href": "https://doi.org/10.1177/1010428317701646"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28466785"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28466785"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Paolo Santini, Laura Politi, Pietro Dalla Vedova, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The inflammatory circuitry of miR-149 as a pathological mechanism in osteoarthritis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Rheumatol Int (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00296-013-2754-8"}], "href": "https://doi.org/10.1007/s00296-013-2754-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23595570"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23595570"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Zi Wang, Jialei Hu, Yue Pan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-140-5p/miR-149 Affects Chondrocyte Proliferation, Apoptosis, and Autophagy by Targeting FUT1 in Osteoarthritis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Inflammation (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10753-018-0750-6"}], "href": "https://doi.org/10.1007/s10753-018-0750-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29488053"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29488053"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Fabio Arturo Grieco, Guido Sebastiani, Jonas Juan-Mateu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNAs miR-23a-3p, miR-23b-3p, and miR-149-5p Regulate the Expression of Proapoptotic BH3-Only Proteins DP5 and PUMA in Human Pancreatic β-Cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2337/db16-0592"}], "href": "https://doi.org/10.2337/db16-0592"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27737950"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27737950"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Su-Ling Ding, Jian-Xun Wang, Jian-Qin Jiao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A pre-microRNA-149 (miR-149) genetic variation affects miR-149 maturation and its ability to regulate the Puma protein in apoptosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M112.440453"}], "href": "https://doi.org/10.1074/jbc.M112.440453"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23873935"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23873935"}]}]}]}
|
| Synonyms | MIRN149, MIR-149 |
| NCBI Gene ID | 406941 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR149 has 722 functional associations with biological entities spanning 6 categories (molecular profile, disease, phenotype or trait, functional term, phrase or reference, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 21 datasets.
Click the + buttons to view associations for MIR149 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR149 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR149 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of MIR149 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| CTD Gene-Disease Associations | diseases associated with MIR149 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR149 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR149 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MIR149 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GAD Gene-Disease Associations | diseases associated with MIR149 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with MIR149 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing MIR149 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of MIR149 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MIR149 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of MIR149 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with MIR149 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of MIR149 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR149 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of MIR149 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by MIR149 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MIR149 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of MIR149 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR149 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |